IRIS UniCatt

Mattiucci, Gian Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.718
EU - Europa 5.590
AS - Asia 4.955
SA - Sud America 973
Continente sconosciuto - Info sul continente non disponibili 243
AF - Africa 142
OC - Oceania 18
Totale 20.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.430
SG - Singapore 2.291
DE - Germania 1.979
CN - Cina 1.099
SE - Svezia 996
BR - Brasile 769
IT - Italia 662
FR - Francia 477
VN - Vietnam 463
UA - Ucraina 338
IN - India 266
GB - Regno Unito 260
IE - Irlanda 225
ID - Indonesia 162
FI - Finlandia 149
CA - Canada 133
RU - Federazione Russa 107
JP - Giappone 104
TR - Turchia 101
PL - Polonia 89
BD - Bangladesh 79
AR - Argentina 74
HK - Hong Kong 74
BE - Belgio 63
IQ - Iraq 58
MX - Messico 55
NL - Olanda 50
CZ - Repubblica Ceca 40
EC - Ecuador 36
ZA - Sudafrica 36
CI - Costa d'Avorio 34
IR - Iran 31
SA - Arabia Saudita 31
ES - Italia 30
CO - Colombia 28
AT - Austria 27
PK - Pakistan 26
VE - Venezuela 21
PH - Filippine 19
JM - Giamaica 16
AU - Australia 15
CR - Costa Rica 14
MA - Marocco 14
NI - Nicaragua 14
TN - Tunisia 14
UZ - Uzbekistan 14
AZ - Azerbaigian 13
CL - Cile 13
KR - Corea 13
CH - Svizzera 12
KE - Kenya 12
LT - Lituania 12
UY - Uruguay 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
EU - Europa 9
IL - Israele 9
PS - Palestinian Territory 9
RO - Romania 9
TT - Trinidad e Tobago 9
EG - Egitto 8
HN - Honduras 8
KZ - Kazakistan 8
NO - Norvegia 8
DK - Danimarca 7
NP - Nepal 7
PE - Perù 7
SV - El Salvador 7
AL - Albania 6
AM - Armenia 6
BO - Bolivia 6
LK - Sri Lanka 6
LU - Lussemburgo 6
PT - Portogallo 6
PY - Paraguay 6
TH - Thailandia 6
BB - Barbados 5
GR - Grecia 5
KG - Kirghizistan 5
KW - Kuwait 5
MY - Malesia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
BG - Bulgaria 4
BZ - Belize 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
NG - Nigeria 4
PA - Panama 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
DZ - Algeria 3
GT - Guatemala 3
LB - Libano 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AG - Antigua e Barbuda 2
Totale 20.368
Salva come PNG Salva come JPEG
Città #
Singapore 1.244
Chandler 1.082
Ashburn 938
San Jose 699
Jacksonville 249
Beijing 240
Dublin 224
New York 222
Ann Arbor 216
San Mateo 202
The Dalles 199
Los Angeles 180
Council Bluffs 171
Ho Chi Minh City 154
Dearborn 146
Nanjing 137
Wilmington 137
Jakarta 134
Lauterbourg 132
Milan 127
Munich 122
Woodbridge 117
Boston 116
Hanoi 108
Frankfurt am Main 98
Nürnberg 92
Tokyo 92
Dallas 81
Princeton 74
Marseille 73
Rome 72
Warsaw 72
São Paulo 71
Hong Kong 70
Bremen 67
Izmir 66
Hefei 62
Houston 62
Brussels 61
Fairfield 60
Hyderabad 60
Santa Clara 60
Cattolica 59
Lawrence 55
Moscow 52
Helsinki 50
Seattle 50
Buffalo 49
North Bergen 47
Nanchang 45
Chicago 43
Redwood City 43
Boardman 38
London 38
Phoenix 37
Abidjan 34
Atlanta 34
Detroit 34
Brooklyn 33
Zhengzhou 33
Shenyang 29
Kunming 28
Redmond 28
Jiaxing 27
Leawood 27
St Louis 27
Da Nang 26
Memphis 26
Paris 26
Nuremberg 25
Orem 25
Cambridge 24
Johannesburg 24
Toronto 24
Amsterdam 23
Augusta 23
Montreal 23
Shanghai 23
Norwalk 22
Tianjin 21
Changsha 20
Philadelphia 20
Turku 20
Pune 19
Stockholm 19
Tampa 19
Belo Horizonte 18
Haiphong 18
Hebei 18
Kent 18
Las Vegas 18
Ottawa 18
Curitiba 17
Chennai 16
Düsseldorf 16
Rio de Janeiro 16
Baghdad 15
Guangzhou 15
Mexico City 15
Poplar 15
Totale 10.214
Salva come PNG Salva come JPEG
Nome #
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 289
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 280
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 250
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 243
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 238
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 235
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 228
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 227
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 214
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 213
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 212
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 210
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 207
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 206
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 204
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 203
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 201
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 200
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 198
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 198
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 194
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 192
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 192
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 189
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 188
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 185
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 183
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 183
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 182
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 182
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 181
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 179
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 175
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 174
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 174
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 174
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 174
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 173
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 172
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 171
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 170
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 167
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 167
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 166
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 166
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 166
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 164
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 164
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 161
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 159
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 159
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 158
New standards for the management of nose vestibule malignancies 157
The impact of radiomics in diagnosis and staging of pancreatic cancer 157
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 155
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 155
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 154
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 154
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 153
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 153
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 152
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 150
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 150
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 150
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 150
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 149
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 149
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 148
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 147
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 145
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 145
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 143
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 139
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 138
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 138
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 138
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 137
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 136
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 135
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 135
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 135
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 134
Can automation in radiotherapy reduce costs? 134
Radiation therapy for prostate cancer: What's the best in 2021 133
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 132
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 132
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 131
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 130
Prostheses irradiation in high risk breast cancer patients: clinical and aesthetic outcomes in retrospective series 129
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 128
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 127
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 127
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 126
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 125
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 125
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 124
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 123
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 122
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 120
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 120
Totale 16.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.059 0 0 0 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/20252.533 58 87 176 95 270 83 77 130 394 268 508 387
2025/20266.301 952 175 313 670 1.149 313 1.132 335 457 459 203 143
2026/20271.991 213 296 442 1.040 0 0 0 0 0 0 0 0
Totale 20.639